Table 1.
Baseline demographic, clinical, and treatment characteristics of patients analyzed.
| Characteristic | Value | |
|---|---|---|
|
| ||
| Sex | ||
| Female | 30 (24.0%) | |
| Male | 95 (76.0%) | |
|
| ||
| Age | ||
| Mean | 65.9 years | |
| Median | 65.6 years | |
| Range | 39.6–85.2 years | |
|
| ||
| Race/Ethnicity | ||
| Caucasian | 120 (96.0%) | |
| African American | 3 (2.4%) | |
| Asian | 1 (0.8%) | |
| Not reported | 1 (0.8%) | |
|
| ||
| KPS | ||
| >= 70 | 122 (97.6%) | |
| < 70 | 3 (2.4%) | |
|
| ||
| Smoking Status | ||
| Former smoker | 61 (48.8%) | |
| Current smoker | 53 (42.4%) | |
| Never smoker | 7 (5.6%) | |
| Not reported | 4 (3.2%) | |
|
| ||
| Group Stage | ||
| I | 11 (8.8%) | |
| II | 13 (10.4%) | |
| III | 100 (80.0%) | |
| IV | 1 (0.8%) | |
|
| ||
| T Stage | ||
| T1 | 21 (16.8%) | |
| T2 | 29 (23.2%) | |
| T3 | 36 (28.8%) | |
| T4 | 38 (30.4%) | |
| Tx | 1 (0.8%) | |
|
| ||
| N Stage | ||
| N0 | 28 (22.4%) | |
| N1 | 15 (12.0%) | |
| N2 | 55 (44.0%) | |
| N3 | 27 (21.6%) | |
|
| ||
| Target Radiation Dose (BED) | ||
| Mean | 70.2 Gy (87.3 Gy) | |
| Median | 70.0 Gy (84.0 Gy) | |
| Range | 34.0 – 87.9 Gy (40.8 – 115.5 Gy) | |
|
| ||
| Mean Lung Dose | ||
| Mean | 14.1 Gy | |
| Interquartile range | 11.6 – 17.2 Gy | |
| Range | 3.0 – 25.8 Gy | |
|
| ||
| Concurrent Chemotherapy | ||
| No | 20 (16.0%) | |
| Yes | 105 (84.0%) | |
BED = Biologic equivalent dose. KPS = Karnofsky performance status. Gy = Gray.